News archive

465 stories

Yale University / Nature Medicine · 29 Sept 2026 · Supplements / medicine

Across 51 trials, eating patterns plus movement lowered epigenetic-age clocks; store-bought products did not

Study (pooled intervention analysis). Raghav Sehgal and colleagues at Yale report in Nature Medicine (doi 10.1038/s41591-026-04562-9; healthmedicinet 29 September 2026) a re-analysis of 51 human intervention studies with more than 110 DNA-methylation biomarkers, including 16 major epigenetic clocks. They grouped the work into clinic-directed products, lifestyle programs, store-bought products, and procedures. Programs that combined a healthy eating pattern (Mediterranean, lower-carbohydrate, or lower-fat) with regular movement consistently lowered epigenetic-age estimates. Clinic-directed metabolic products, including metformin and semaglutide, and anti-TNF biologics that target an immune protein tied to inflammation, produced the largest average clock drops. Store-bought products and some procedures did not lower the clocks in this pool. Newer clocks moved more than older ones, and people who already had disease showed larger biomarker shifts than healthy volunteers. Clocks are not proof of longer life. Educational notes. Educational supplement parallel (not a replacement): When longevity headlines discuss metformin, people often also research berberine. That is an off-label / curiosity parallel, not a recommendation to take berberine instead of metformin. Human longevity outcome data for both are limited; disease-use of metformin is clinician-prescribed. Weakly evidenced as an anti-aging product. Store: /store/berberine. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.

Read at Yale University / Nature Medicine →♡ Save

• Metabolic / glucose

• study
• longevity
• aging
• glp1
• metformin
• off-label-context
• inflammation
• nutrition

University College Cork / Nature Communications · 28 Sept 2026 · Nutrition

In 62 adults, stopping then restarting coffee shifted gut metabolites; decaf lined up with learning scores

Study (observational, small). Serena Boscaini, John F. Cryan, and colleagues at APC Microbiome Ireland, University College Cork, report in Nature Communications (2026; 17(1); doi 10.1038/s41467-026-71264-8; ScienceDaily 28 September 2026). They compared 31 people who usually drank 3 to 5 cups of coffee a day with 31 people who did not. Regular drinkers stopped coffee for two weeks, then restarted without knowing whether they received caffeinated or decaffeinated coffee. Stopping coffee shifted stool and urine metabolite profiles. After coffee returned, both groups reported lower perceived stress, depression, and impulsivity scores. Eggertella and Cryptobacterium curtum were more abundant in coffee drinkers. Improved learning and memory scores appeared only in the decaf arm; caffeinated coffee lined up with lower anxiety scores and better vigilance. The study was sponsored by the Institute for Scientific Information on Coffee. Sixty-two people cannot prove that coffee changes mood. Educational notes.

Read at University College Cork / Nature Communications →♡ Save

• Cognitive / dementia research

• study
• gut
• cognition

King's College London / Science Advances · 28 Sept 2026 · Nutrition

Urolithin A from pomegranate, walnut, and berry pathways improved heart relaxation in animals and engineered human tissue

Study (animal and engineered human tissue). Jie Su, Joseph R. Burgoyne, and colleagues at King's College London report in Science Advances (2026; 12(34); doi 10.1126/sciadv.aec8088; ScienceDaily 28 September 2026; British Heart Foundation funded). Urolithin A is made in the body after eating pomegranates, walnuts, and some berries. In models of heart failure with preserved ejection fraction — a stiff heart that still pumps but fills poorly — urolithin A activated PKGlα at a cysteine residue, improved relaxation measures by up to 80% versus untreated models, reduced scarring, and limited cell enlargement. Engineered human heart tissue from stem cells also relaxed more with urolithin A. Burgoyne said there is not enough evidence that people should eat pomegranates to treat this condition. James Leiper of the British Heart Foundation said clinical trials in people are still needed. Educational notes. This is not a food-as-cure claim.

Read at King's College London / Science Advances →♡ Save

• 60+
• Cardiovascular / lipids

• study
• aging

EASD / FIDAM Bad Mergentheim · 28 Sept 2026 · Research

In 400 adults with diabetes, more time in a 70–140 mg/dl glucose band predicted a better next-day quality-of-life score

Study (observational, conference). Dominic Ehrmann of FIDAM, Bad Mergentheim, and colleagues will present PRO-MENTAL analyses at the EASD meeting in Milan (ScienceDaily 28 September 2026). Four hundred adults (72% type 1 diabetes, 28% type 2; 55% women; median age 47, range 32–63; mean HbA1c 7.6%) wore continuous glucose monitors and rated daily quality of life for 14 days with a WHO-5 ecological momentary assessment. More time in 70–140 mg/dl on one day lined up with a better quality-of-life score the next day. Higher-than-usual glucose variability on the prior day also lined up with a better next-day score, which the authors read as a possible cost of trying to flatten every swing. Time above 180 or below 70 mg/dl the previous day did not predict next-day scores. Better sleep and higher energy the day before also predicted better scores. Same-day glucose numbers did not match same-day scores. Models accounted for age, sex, diabetes type, and prior-day scores. Conference data are preliminary. Educational notes. This does not license looser glucose targets.

Read at EASD / FIDAM Bad Mergentheim →♡ Save

• Under 40
• 40–59
• Metabolic / glucose

• study
• sleep

Weill Cornell Medicine / Hospital for Special Surgery / Cell · 28 Sept 2026 · Supplements / medicine

A tendon-and-ligament stem cell was overactive in lumbar spinal stenosis; turning down calcium signaling stopped extra growth in mice

Study (mouse and human surgical tissue). Lingling Hu, Matthew B. Greenblatt, Sravisht Iyer, and colleagues at Weill Cornell Medicine and Hospital for Special Surgery report in Cell (doi 10.1016/j.cell.2026.08.018; ScienceDaily 28 September 2026; paper dated 7 September). They identified a stem-cell population that self-renews and can make tendon and ligament cells, found in mouse connective tissue and in human samples from kneecap ligament, Achilles tendon, and spine. Ligaments from people with lumbar spinal stenosis held more of these cells than ligaments from people with disc herniation without stenosis. Transplanting stenosis-associated cells into mice made more tendon cells. The cells showed higher calcium signaling; raising that signaling in healthy cells triggered extra tissue growth, and lowering it in a mouse stenosis model blocked abnormal growth. The authors say calcium-channel products already used for blood pressure could be studied, and that trials in people have not been done. Educational notes. This is not a reason to change a blood-pressure plan.

Read at Weill Cornell Medicine / Hospital for Special Surgery / Cell →♡ Save

• 60+
• Cardiovascular / lipids

• study
• aging

Université Sorbonne Paris Nord / EASD via Medical Xpress · 27 Sept 2026 · Nutrition

In a French cohort, the highest intake of a red-meat sugar tracked a 63% higher type 2 diabetes risk

Study (observational, preliminary). Leopold Fezeu of Université Sorbonne Paris Nord and colleagues presented an analysis of the NutriNet-Santé cohort at the EASD meeting in Milan (Medical Xpress 27 September 2026). Among 89,953 adults without diabetes or cancer at the start (average age 42; 79% women), dietary N-glycolylneuraminic acid (Neu5Gc) was estimated from three 24-hour food records. Humans do not make Neu5Gc. It is common in red meat, especially beef and lamb, and lower in dairy. Over a median 7.2 years, 966 people developed type 2 diabetes. The highest fifth of meat-derived Neu5Gc had a 63% higher risk than the lowest fifth after accounting for age, sex, activity, diet quality, smoking, and other conditions. The second-highest fifth had a 41% higher risk. The association was seen in men and in women. In the highest fifth, men ate a median 97 g of red meat a day (136 g including processed meat) and women 73 g (96 g including processed meat). After also accounting for total red meat, the Neu5Gc association weakened and was no longer statistically significant, so the sugar may explain part of the meat link, not all of it. Dairy-derived Neu5Gc was not associated with diabetes. The authors estimate obesity accounted for about 13% of the meat-derived association. Results are preliminary and not yet finalized. This is not proof that cutting beef prevents diabetes. Educational notes.

Read at Université Sorbonne Paris Nord / EASD via Medical Xpress →♡ Save

• 40–59
• Metabolic / glucose

• study

Charles University / EASD via Medical Xpress · 27 Sept 2026 · Research

In 22 medical students, blood sugar peaked on exam day and tracked how stressed they felt

Study (observational, small). Jan Broz, Natalia Michalcova, and colleagues at Charles University and Motol University Hospital in Prague used continuous glucose monitors on 22 healthy second-year medical students (13 women and 9 men; average age 21; average BMI 21.9) around one biochemistry exam (EASD, Milan; Medical Xpress 27 September 2026). Sensors recorded glucose every 15 minutes from seven days before the exam until three days after. The highest average daily glucose was on exam day, 5.72 mmol/L, up 0.37 mmol/L from 5.35 mmol/L four days earlier, then 5.42 mmol/L the next day. Overnight glucose rose from 4.70 mmol/L seven nights before to 4.93 mmol/L the night before. During the exam, the written test had the highest average, 6.14 mmol/L. Students who scored higher stress on the State-Trait Anxiety Inventory had a higher average glucose before the exam and a sharper drop afterward. Daily averages stayed inside a range the authors called healthy in the short term. One exam in 22 students cannot show that stress causes diabetes. Educational notes.

Read at Charles University / EASD via Medical Xpress →♡ Save

• Women
• Men
• Under 40
• Metabolic / glucose

• study

University of Trento / EASD via Medical Xpress · 27 Sept 2026 · Supplements / medicine

In 229,025 adults, hundreds of gut bacteria lined up with type 2 diabetes before standard glucose tests changed

Study (observational). Gabriel Baldanzi, Nicola Segata, and colleagues, including Tim Spector, analysed gut DNA and health records from 229,025 adults in the United Kingdom and the United States (73.8% women; average age 50) for the EASD meeting in Milan (Medical Xpress 27 September 2026). Of them, 3,627 had type 2 diabetes, 14,022 had prediabetes, and 211,376 had normal glucose measures. After accounting for age, sex, and BMI, 789 bacterial species were associated with type 2 diabetes: 168 more abundant and 621 less abundant. Enterocloster bolteae was more abundant. Romboutsia timonensis was less abundant. Some of the species have never been grown in a lab. The pattern was stronger in people on diabetes medication and was also present in unmedicated diabetes. Of the 789 species, 587 were also associated with unmedicated prediabetes. Among 135,093 people with normal standard glucose tests, those whose blood sugar stayed high longer after a meal were more likely to carry the diabetes-linked pattern. The authors say a microbiome readout should not replace HbA1c or a glucose tolerance test. This is not a diet that was assigned, and it does not show that changing bacteria prevents diabetes. Educational notes.

Read at University of Trento / EASD via Medical Xpress →♡ Save

• 40–59
• Metabolic / glucose

• study
• gut
• nutrition

Stanford Medicine / Public Health Nutrition · 27 Sept 2026 · Supplements / medicine

Food-service directors in 20 California districts named budget, staff, and kitchens as the barriers to dropping ultra-processed school meals

Commentary (interview study). Anisha Patel, Andrea Pedroza-Tobias, and colleagues at Stanford Medicine report in Public Health Nutrition (doi 10.1017/S1368980026103139; Medical Xpress 27 September 2026) on interviews with food-service directors in 20 school districts in California's San Joaquin Valley. California's AB 1264, the Real Food, Healthy Kids Act, requires schools to remove certain ultra-processed foods from menus by 1 July 2035, with a phase-in from July 2029. Directors named budget, staffing, procurement, and kitchen equipment as the largest barriers. Districts are reimbursed about $4.60 per lunch. Heat-and-serve items are cheap. Scratch cooking needs time, full-time staff, and permitted kitchens. In Fresno, adding sinks, drains, and hoods at about 50 elementary schools was described as a cost in the millions, so sandwiches were made in a central kitchen instead. One-year grants were not enough for lasting changes. One district that cooks mostly from scratch had a director who was both a chef and trained in nutrition, and it invited students to submit recipes. Patel said the upfront cost is an investment against later obesity, type 2 diabetes, and cardiovascular disease. This is a study of implementation barriers, not a trial that assigned a menu. Educational notes.

Read at Stanford Medicine / Public Health Nutrition →♡ Save

• Under 40
• Metabolic / glucose

• commentary
• nutrition
• study

Karolinska Institutet / BMC Medicine · 27 Sept 2026 · Supplements / medicine

In 1,769 adults over 60, three healthy eating patterns tracked higher folate and lower GDF-15

Study (cross-sectional). Rachel Ann Da Costa, Adrián Carballo-Casla, and colleagues at Karolinska Institutet report in BMC Medicine (doi 10.1186/s12916-026-05202-2; Medical Xpress 27 September 2026) on 1,769 people aged 60 and older in the Swedish National Study on Aging and Care in Kungsholmen. Participants described their diet over the past year. Researchers compared three patterns — an alternative Mediterranean score, the Alternative Healthy Eating Index, and a reverse Empirical Dietary Inflammatory Index — with 54 blood biomarkers. Greater adherence lined up with higher folate and lower growth differentiation factor 15 on all three patterns. The lower-inflammatory pattern lined up with the largest number of biomarkers, especially those tied to inflammation and metabolism. Other links differed by pattern. The snapshot cannot show that changing diet changes the markers. Participants were mostly older adults from Stockholm with relatively high education. Educational notes.

Read at Karolinska Institutet / BMC Medicine →♡ Save

• 60+

• study
• nutrition
• aging
• inflammation

European Academy of Neurology / Sleep Medicine Reviews · 27 Sept 2026 · Supplements / medicine

An umbrella review linked insomnia with a 26% higher stroke risk and a 28% higher chance of hospital admission

Study (umbrella review). Luca Vignatelli of the IRCCS Istituto delle Scienze Neurologiche di Bologna and Stefan Seidel report in Sleep Medicine Reviews (doi 10.1016/j.smrv.2026.102372; Medical Xpress 27 September 2026). They combined existing reviews with new reviews of stroke, occupational injury, and hospitalization, searching MEDLINE and EMBASE through August 2025. For stroke, six of nine eligible studies entered the meta-analysis, covering more than 1.3 million people. Insomnia was associated with a 26% higher stroke risk (hazard ratio 1.26; 95% CI 1.05 to 1.53), with wide differences between studies. Across hospitalization studies, the odds of admission for any reason were 28% higher (odds ratio 1.28; 95% CI 1.14 to 1.43). The wider evidence also linked insomnia with depression and suicidal behavior, and most reviews linked it with all-cause dementia, more consistently with Alzheimer's disease than with vascular dementia. A prior meta-analysis estimated that insomnia meeting diagnostic criteria affects about 22% of people. Definitions of insomnia differed, and sleep-medicine use was rarely considered. The review does not show that treating insomnia prevents stroke. Educational notes.

Read at European Academy of Neurology / Sleep Medicine Reviews →♡ Save

• Cardiovascular / lipids
• Cognitive / dementia research

• study
• sleep
• cognition

Copenhagen University Hospital / EASD via Medical Xpress · 27 Sept 2026 · Supplements / medicine

In two large cohorts, about half of adults with a BMI of 25 to 26.9 had a heart-disease risk like people already eligible for GLP-1 drugs

Study (observational). Karen Hvid of Copenhagen University Hospital and colleagues compared coronary heart disease risk in the UK Biobank and the Copenhagen General Population Study for the EASD meeting in Milan (Medical Xpress 27 September 2026). The cohorts included 313,145 adults with a BMI of 25 or higher, free of coronary disease and diabetes at the start (median age 58; about half women). Over more than 10 years, 23,134 developed coronary heart disease. About two-thirds (204,850) already met a current weight-loss indication for a GLP-1 receptor agonist such as semaglutide or tirzepatide. Of those with a BMI of 25 to 26.9, who are outside that indication, about half (44% in Copenhagen and 48% in the UK Biobank) had high remnant cholesterol, low-grade inflammation, or both. That subgroup's extra risk of coronary disease was similar to the extra risk in people who already qualified: 41% higher in Copenhagen and 47% higher in the UK Biobank versus people in the same BMI band with healthier cholesterol and inflammation. People who already qualified had a 41% and 35% higher risk in the two cohorts. The authors say trials are needed before any change in who is prescribed these drugs. This analysis did not give anyone a GLP-1 medicine. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. Educational notes. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.

Read at Copenhagen University Hospital / EASD via Medical Xpress →♡ Save

• 40–59
• Cardiovascular / lipids
• Metabolic / glucose

• study
• inflammation
• glp1
• off-label-context

VitaLonga is an educational longevity resource, not a pharmacy, clinic, or doctor. Content is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease (DSHEA). Supplements can interact with medications and are not appropriate in every pregnancy or health condition. Consult a licensed clinician, especially if you take medications, are pregnant or nursing, or have a diagnosed condition.